Progyny, Inc. (NasdaqGS: PGNY)
Health Care · Health Care Providers & Services · US
$27.85
-0.29% today · +35.8% 1Y
Progyny, Inc. (NasdaqGS: PGNY) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $2.14B and employs 846 people.
Over the last twelve months the share price has gained 35.8%, trading between 16.10 and 33.07.
Tweenvest scores Progyny, Inc. across four factors: quality 72/100, value 72/100, growth 84/100. Its strongest factor is growth.
PGNY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.14B
- Revenue (TTM)
- $1.31B
- P/E
- 30.79
- EPS
- 0.91
- Dividend yield
- —
- Beta (5Y)
- 1.02
- 52-week high
- $33.07
- 52-week low
- $16.10
- Avg volume (3M)
- —
- Shares outstanding
- 76.73M
- Employees
- 846
- Next earnings
- —
About Progyny, Inc.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
- ISIN
- US74340E1038
- Founded
- 2008
- Listed since
- Oct 25, 2019
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Brookdale Senior Living Inc.NYSE: BKD | $2.42B | $10.18 | +0.54% |
| Topchoice Medical Co., Inc.SHSE: 600763 | $2.26B | CN¥33.80 | -0.79% |
| Suzuken Co., Ltd.TSE: 9987 | $2.22B | ¥2,600.00 | +0.37% |
| EBOS Group LimitedNZSE: EBO | $2.20B | NZ$18.98 | +0.74% |
| Pediatrix Medical Group, Inc.NYSE: MD | $2.11B | $26.99 | +1.30% |
| NeoGenomics, Inc.NasdaqCM: NEO | $2.10B | $16.14 | -1.28% |
| Dr. Soliman Abdel Kader Fakeeh Hospital CompanySASE: 4017 | $2.10B | SR34.28 | -0.35% |
| Addus HomeCare CorporationNasdaqGS: ADUS | $2.09B | $117.29 | +2.59% |
Figures last refreshed Oct 11, 2026.